Evidence map›Paper›PMID 36977134›Full record

ArticleTropical medicine and infectious disease2023

Factors Associated with COVID-19 Death in a High-Altitude Peruvian Setting during the First 14 Months of the Pandemic: A Retrospective Multicenter Cohort Study in Hospitalized Patients.

Fátima Concha-Velasco, Ana G Moncada-Arias, María K Antich, Carolina J Delgado-Flores, Cesar Ramírez-Escobar, Marina Ochoa-Linares, Lucio Velásquez-Cuentas, Homero Dueñas de la Cruz, Steev Loyola

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. OMedicina (Kaunas, Lithuania) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Fátima Concha-VelascoUniversidad Continental, Cusco 08000, Peru.
Ana G Moncada-AriasDirección de Epidemiología e Investigación, Gerencia Regional de Salud (GERESA), Cusco 08200, Peru.ORCID 0000-0002-0341-0457
María K AntichDirección de Epidemiología e Investigación, Gerencia Regional de Salud (GERESA), Cusco 08200, Peru.
Carolina J Delgado-FloresInstituto de Evaluación de Tecnologías en Salud e Investigación, EsSalud, Lima 15072, Peru.
Cesar Ramírez-EscobarDirección de Epidemiología e Investigación, Gerencia Regional de Salud (GERESA), Cusco 08200, Peru.
Marina Ochoa-LinaresHospital Regional del Cusco, Cusco 08003, Peru.
Lucio Velásquez-CuentasHospital Nacional Adolfo Guevara Velasco-EsSalud, Cusco 08002, Peru.ORCID 0000-0002-6911-9689
Homero Dueñas de la CruzHospital Antonio Lorena, Cusco 08001, Peru.
Steev LoyolaFacultad de Medicina, Universidad Peruana Cayetano Heredia, Lima 150135, Peru.ORCID 0000-0001-5455-2423
Dirección Regional de Salud del Callao · PEUniversidad Andina del Cusco · PEEsSALUD · PEUniversidad Peruana Cayetano Heredia · PEUniversity of Cartagena · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Risk factors for COVID-19 death in high-altitude populations have been scarcely described. This study aimed to describe risk factors for COVID-19 death in three referral hospitals located at 3399 m in Cusco, Peru, during the first 14 months of the pandemic. A retrospective multicenter cohort study was conducted. A random sample of ~50% (1225/2674) of adult hospitalized patients who died between 1 March 2020 and 30 June 2021 was identified. Of those, 977 individuals met the definition of death by COVID-19. Demographic characteristics, intensive care unit (ICU) admission, invasive respiratory support (IRS), disease severity, comorbidities, and clinical manifestation at hospital admission were assessed as risk factors using Cox proportional-hazard models. In multivariable models adjusted by age, sex, and pandemic periods, critical disease (vs. moderate) was associated with a greater risk of death (aHR: 1.27; 95%CI: 1.14-1.142), whereas ICU admission (aHR: 0.39; 95%CI: 0.27-0.56), IRS (aHR: 0.37; 95%CI: 0.26-0.54), the ratio of oxygen saturation (ROX) index ≥ 5.3 (aHR: 0.87; 95%CI: 0.80-0.94), and the ratio of SatO

Indexed as

COVID-19Cuscodeathhigh altitudehospitalizationintensive care unitsmechanical ventilatorPerurisk factors

Identifiers

PMID36977134
PMCPMC10051565
OpenAlexW4321599137

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.